The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling
Open accessAbstract
Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prominent therapeutic efficacy of unmodified mRNA is possibly due to activation of endosomal toll-like receptor 7/8 (TLR7/8) and subsequently causes pro-inflammatory cytokine secretion via MyD88-dependent IRF-5 phosphorylation (41).”
From mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model (2022) · cites this paper as [41]
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,577
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M. L., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,854
Flagged first, then by citations
Research works printed but not linked: 4
- Chuang, 2000, Eur. Cytokine Netw., 11, 372
- Du, 2000, Eur. Cytokine Netw., 11, 362
- von Krogh, 2001, Eur. J. Dermatol., 11, 598
- Maniatis, 1986, Harvey Lect., 82, 71
Cited by
Sorted by citations
Items 201–300 of 411
Evaluation of T cell cytokines and their role in recurrent miscarriage
Ali, S., Majid, S., Ali, M. N., & Taing, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106347 · Cited by 41
Toll-Like Receptor 7 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1
Valente, R. M., Ehlers, E., Xu, D., Ahmad, H., Steadman, A., Blasnitz, L., Zhou, Y., Kastanek, L., Meng, B., & Zhang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043317 · Cited by 39
Type I Interferon: The Ever Unfolding Story
Pitha, P. M., & Künzi, M. S. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_4 · Cited by 39
Liu, B., Liu, Q., Yang, L., Palaniappan, S. K., Bahar, İ., Thiagarajan, P. S., & Ding, J. L. (2016) · Science Signaling · doi:10.1126/scisignal.aac9340 · Cited by 38
Maestre‐Batlle, D., Pena, O. M., Huff, R. D., Randhawa, A., Carlsten, C., & Bølling, A. K. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.07.046 · Cited by 38
Nonendocrine mechanisms of sex bias in rheumatic diseases
Lambert, N. C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0307-6 · Cited by 39
Lazear, H. M., Lancaster, A. M., Wilkins, C. R., Suthar, M. S., Huang, A., Vick, S. C., Clepper, L., Thackray, L. B., Brassil, M. M., Virgin, H. W., et al. (2013) · PLoS Pathogens · doi:10.1371/annotation/4de7ddfd-52df-4f87-8ca4-d48afe646ca8 · Cited by 39
Rupasree, Y., Naushad, S. M., Rajasekhar, L., Uma, A., & Kutala, V. K. (2014) · Lupus · doi:10.1177/0961203314549792 · Cited by 37
Activation of plasmacytoid dendritic cells
Fuchsberger, M., Hochrein, H., & O’Keeffe, M. A. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01392.x · Cited by 36
Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis
Matta, B., & Barnes, B. J. (2019) · Cytokine · doi:10.1016/j.cyto.2019.05.018 · Cited by 36
Liu, S. Q., Alkema, P. K., Tieché, C., Tefft, B. J., Liu, D. Z., Li, Y. C., Sumpio, B. E., Caprini, J. A., & Paniagua, M. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503866200 · Cited by 35
Interferon gene regulation: not all roads lead to Tolls
Jefferies, C. A., & Fitzgerald, K. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.07.006 · Cited by 35
RNA regulatory mechanisms that control antiviral innate immunity
Gokhale, N. S., Smith, J. R., Gelder, R. D. V., & Savan, R. (2021) · Immunological Reviews · doi:10.1111/imr.13019 · Cited by 34
Innate immune processes in lupus erythematosus
Aringer, M., Günther, C., & Lee‐Kirsch, M. A. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.11.012 · Cited by 35
Human Immunodeficiency Virus 1 and Type I Interferons—Where Sex Makes a Difference
Ziegler, S. M., & Altfeld, M. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01224 · Cited by 34
Vosslamber, S., van der Voort, L. F., van den Elskamp, I. J., Heijmans, R., Aubin, C., Uitdehaag, B. M. J., Crusius, J. B. A., Kraan, T. C. T. M. V. D. P., Comabella, M., Montalbán, X., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.18 · Cited by 34
Toll-like Receptor 7 Contributes to Inflammation, Organ Injury, and Mortality in Murine Sepsis
Jian, W., Gu, L., Williams, B., Feng, Y., Chao, W., & Zou, L. (2019) · Anesthesiology · doi:10.1097/aln.0000000000002706 · Cited by 34
Roberts, B. K., Collado, G., & Barnes, B. J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189061 · Cited by 36
Barnes, B. J. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0803-3 · Cited by 33
A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
Iavarone, C., Ramsauer, K., Kubarenko, A. V., Debasitis, J. C., Leykin, I., Weber, A. N. R., Siggs, O. M., Beutler, B., Zhang, P., Otten, G. R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003585 · Cited by 33
Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways
Chu, Y.-T., Liao, M.-T., Tsai, K., Lu, K., & Hu, W. (2023) · Biomedicines · doi:10.3390/biomedicines11092384 · Cited by 32
Innate Antiviral Response: Role in HIV-1 Infection
Pitha, P. M. (2011) · Viruses · doi:10.3390/v3071179 · Cited by 34
Hu, G., Lou, H., Dong, X., Liu, Q.-M., & Zhang, S. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.06.001 · Cited by 32
IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases
Yang, Y., Zhang, C., Jing, D., He, H., Li, X., Wang, Y., Qin, Y., Xiao, X., Xiong, H., & Zhou, G. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa200 · Cited by 32
Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics
Huang, X., Zhang, X., & Lu, M. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1898369 · Cited by 32
IRF 5, IRF 8, and IRF 7 in human p DC s — the good, the bad, and the insignificant?
Pelka, K., & Latz, E. (2013) · European Journal of Immunology · doi:10.1002/eji.201343739 · Cited by 31
Yasuda, K., Watkins, A. A., Kochar, G. S., Wilson, G. E., Laskow, B., Richez, C., Bonegio, R. G. B., & Rifkin, I. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103478 · Cited by 31
The Wheel of p53 Helps to Drive the Immune System
Łasut-Szyszka, B., & Rusin, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087645 · Cited by 31
The Innate Antiviral Response: New Insights Into A Continuing Story
Paun, A., & Pitha, P. M. (2006) · Advances in virus research · doi:10.1016/s0065-3527(06)69001-5 · Cited by 31
Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases
Zhang, Y., & Li, H. (2017) · Physiology · doi:10.1152/physiol.00038.2016 · Cited by 32
Thackray, L. B., Shrestha, B., Richner, J. M., Miner, J. J., Pinto, A. K., Lazear, H. M., Gale, M., & Diamond, M. (2014) · Journal of Virology · doi:10.1128/jvi.01545-14 · Cited by 30
Forbester, J. L., Clement, M., Wellington, D., Yeung, A. T. Y., Dimonte, S., Marsden, M., Chapman, L., Coomber, E. L., Tolley, C., Lees, E. A., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00121-20 · Cited by 30
Monoallelic IRF5 deficiency in B cells prevents murine lupus
Pellerin, A., Yasuda, K., Cohen‐Bucay, A., Sandra, V., Shukla, P., Horne, B., Nündel, K., Viglianti, G. A., Xie, Y., Klein, U., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.141395 · Cited by 29
Cannova, J., Breslin, P., & Zhang, J. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0412-0 · Cited by 29
Type I IFN – A blunt spear in fighting HIV-1 infection
Acchioni, C., Marsili, G., Perrotti, E., Remoli, A. L., Sgarbanti, M., & Battistini, A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.10.004 · Cited by 33
Yano, H., Uchida, M., Nakai, R., Ishida, K., Kato, Y., Kawanishi, N., & Shiva, D. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1560-1 · Cited by 29
Domingues, R., de Carvalho, G. C., Oliveira, L. M. D. S., Taniguchi, E. F., Zimbres, J. M., Aoki, V., Duarte, A. J. D. S., & Sato, M. N. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13214 · Cited by 29
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma
Ternovoi, V. V., Curiel, D. T., Smith, B. F., & Siegal, G. P. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700444 · Cited by 29
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization
Banga, J., Srinivasan, D. K., Sun, C.-C., Thompson, C. D., Milletti, F., Huang, K., Hamilton, S. M., Song, S., Hoffman, A. F., Qin, Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay1057 · Cited by 29
Nagpal, K., Plantinga, T. S., Sirois, C. M., Monks, B. G., Latz, E., Netea, M. G., & Golenbock, D. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199653 · Cited by 33
García-Bermúdez, M., López‐Mejías, R., Genre, F., Castañeda, S., Llorca, J., González‐Juanatey, C., Corrales, A., Ubilla, B., Miranda-Filloy, J. A., Pina, T., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4608 · Cited by 27
Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5
Yang, L., Zhao, T., Shi, X., Nakhaei, P., Wang, Y., Sun, Q., Hiscott, J. B., & Lin, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005500 · Cited by 27
Association ofIRF5gene polymorphisms with rheumatoid arthritis in a Tunisian population
Maalej, A., Hamad, M. B., Rebaï, A., Teixeira, V., Bahloul, Z., Marzouk, S., Farid, N. R., Ayadi, H., Cornélis, F., & Petit, É. (2008) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740802256327 · Cited by 27
Xia, J., Hu, G., Dong, X., Liu, Q.-M., & Zhang, S. (2011) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2011.10.021 · Cited by 26
The role of O-GlcNAcylation in innate immunity and inflammation
Wang, Y., Fang, X., Wang, S., Wang, B., Chu, F., Tian, Z., Zhang, L., & Zhou, F. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac065 · Cited by 26
Brodsky, L., Wahed, A. S., Li, J., Tavis, J. E., Tsukahara, T., & Taylor, M. W. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000584 · Cited by 25
Wüst, S., Schad, P. S., Burkart, S. S., & Binder, M. (2021) · Cells · doi:10.3390/cells10102600 · Cited by 24
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
Rubio‐Casillas, A., Cowley, D., Raszek, M., Uversky, V. N., & Redwan, E. M. M. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131427 · Cited by 27
Chow, K. T., Wilkins, C. R., Narita, M., Green, R. R., Knoll, M. L., Loo, Y., & Gale, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800221 · Cited by 24
Signalling pathways mediating type I interferon gene expression
Edwards, M. R., Slater, L., & Johnston, S. L. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.06.008 · Cited by 24
Yamaguchi, R., Sakamoto, A., Yamamoto, T., 楢原, 真., Sugiuchi, H., & Yamaguchi, Y. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.014 · Cited by 23
IFN Regulatory Factors and Antiviral Innate Immunity: How Viruses Can Get Better
Marsili, G., Perrotti, E., Remoli, A. L., Acchioni, C., Sgarbanti, M., & Battistini, A. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0002 · Cited by 22
Choo, M., Sano, Y., Kim, C., Yasuda, K., Li, X.-D., Lin, X., Stenzel‐Poore, M. P., Alexopoulou, L., Ghosh, S., Latz, E., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161141 · Cited by 22
Tsiplakou, E., Mavrommatis, A., Skliros, D., Righi, F., & Flemetakis, E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233192 · Cited by 22
Irf5 siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury
Kawase, W., Kurotaki, D., Suzuki, Y., Ishihara, H., Ban, T., Sato, G. R., Ichikawa, J., Yanai, H., Taniguchi, T., Tsukahara, K., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.08.023 · Cited by 22
An, W., Lakhina, S., Leong, J., Rawat, K., & Husain, M. (2024) · Pathogens · doi:10.3390/pathogens13070561 · Cited by 23
Korczeniewska, J., & Barnes, B. J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00802-12 · Cited by 21
RetractedBi, X., Feng, D., Korczeniewska, J., Alper, N., Hu, G., & Barnes, B. J. (2013) · Oncogene · doi:10.1038/onc.2013.295 · Cited by 21
Bandyopadhyay, U., Chadha, A., Gupta, P., Tiwari, B. K., Bhattacharyya, K., Popli, S., Rajagopal, R., Brahamachari, V., Singh, Y. P., Malhotra, P., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0217-042r · Cited by 21
The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFAT
Wang, D., Fasciano, S., & Li, L. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.023 · Cited by 21
Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality
Li, D., De, S., Li, D., Song, S., Matta, B., & Barnes, B. J. (2016) · Scientific Reports · doi:10.1038/srep31002 · Cited by 19
Chen, H., Hou, Y., Zhai, Y., Yang, J., Que, L., Liu, J., Lu, L., Ha, T., Li, C., Xu, Y., et al. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac012 · Cited by 21
Wang, X., Guo, J., Wang, Y., Xiao, Y., Wang, L., & Hua, S. (2018) · Medical Science Monitor · doi:10.12659/msm.910756 · Cited by 20
Yu, X., Rehman, A. U., Dang, L., Zhang, X., Liu, J., Xiong, X., Chen, G., & Jian, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1535823 · Cited by 19
HIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 (IRF5) and Inhibits Its Function
Cheng, X., & Ratner, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534321 · Cited by 20
Chen, K., Yu, C., Kung, S., Chen, S., Chang, C., Ho, T., Lee, Y.-P., Chang, H.-C., Huang, L.-Y., Lo, S., et al. (2018) · Viruses · doi:10.3390/v10120689 · Cited by 19
Ishihara, R., Watanabe, R., Shiomi, M., Fujita, Y., Katsushima, M., Fukumoto, K., Yamada, S., & Hashimoto, M. (2025) · Biomolecules · doi:10.3390/biom15111586 · Cited by 20
Mikael Adner, A., Starkhammar, M., Georén, S. K., Dahlén, S., & Cardell, L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.09.004 · Cited by 18
Tang, J., Cheng, X., Yi, S., Zhang, Y., Tang, Z., Zhong, Y., Zhang, Q., Pan, B., & Luo, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.773592 · Cited by 18
Lee, W. H., Wu, H., Lee, C. G., Sung, D. I., Song, H. J., Matsui, T., Kim, H. B., & Kim, S. G. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3070 · Cited by 18
Wickramaarachchi, W. D. N., Wan, Q., Lim, B.-S., Jung, H.-B., Zoysa, M. D., Park, M.-A., Lee, J., & Whang, I. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.02.002 · Cited by 18
Chua, K. H., Lian, L. H., Khor, W. C., Lee, W. S., Hilmi, I. N., Goh, K., & Kee, B. P. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12229 · Cited by 18
Ai, K., Luo, K., Xia, L., Gao, W., Hu, W., Qi, Z., & Xu, Q. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.10.042 · Cited by 17
Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeutics
Hu, G., & Barnes, B. J. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.5.775 · Cited by 17
Sexual dimorphism in HIV-1 infection
Rechtien, A., & Altfeld, M. A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0704-y · Cited by 16
Zhou, H., Wang, X., Cheng, R., Hou, X., Chen, Y., Feng, Y., & Qiu, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14689 · Cited by 16
Guo, J., Wang, X., Wang, Y., Wang, L., & Hua, S. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.07.008 · Cited by 16
Zervou, M. I., Dorschner, J. M., Ghodke‐Puranik, Y., Boumpas, D. T., Niewold, T. B., & Goulielmos, G. (2017) · Gene · doi:10.1016/j.gene.2017.02.003 · Cited by 15
Han, W., Chen, X., Wang, X., Shen, Z., Wang, X., Zhang, Z., & Wang, H. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8825 · Cited by 15
Gokulan, K., Kumar, A., Lahiani, M. H., Sutherland, V. L., Cerniglia, C. E., & Khare, S. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa177 · Cited by 16
Laustsen, A., van der Sluis, R. M., Gris‐Oliver, A., Hernández, S. S., Cémalovic, E., Tang, H. Q., Pedersen, L. H., Uldbjerg, N., Jakobsen, M. R., & Bak, R. O. (2021) · eLife · doi:10.7554/elife.65528 · Cited by 15
The TIR-Domain Containing Adaptor TRAM Is Required for TLR7 Mediated RANTES Production
Shevlin, E., & Miggin, S. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107141 · Cited by 15
Grass carp (Ctenopharyngodon idellus) TRAF6 up-regulates IFN1 expression by activating IRF5
Li, Y., Mao, Y., Yu, N., Xu, X., Li, M., Jiang, Z., Wu, C., Xu, K., Chang, K., Wang, S., et al. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103475 · Cited by 14
Bi, X., Yang, L., Mancl, M. E., & Barnes, B. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0084 · Cited by 15
Roles of IRF4 in various immune cells in systemic lupus erythematosus
Xiao, Z. X., Liang, R., Olsen, N. J., & Zheng, S. G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112077 · Cited by 14
Hepatocyte-targeted delivery of imiquimod reduces hepatitis B virus surface antigen
Fayez, N. A., Rouhollahi, E., Ong, C. Y., Wu, J., Nguyen, A., Böttger, R., Cullis, P. R., Witzigmann, D., & Li, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.058 · Cited by 14
Association of the IRF5 rs2070197 polymorphism with systemic lupus erythematosus: a meta-analysis
Li, Y., Chen, S., Li, P., Wu, Z., Liu, B., Liu, B., Zhang, F., & Li, Y. (2015) · Clinical Rheumatology · doi:10.1007/s10067-015-3036-5 · Cited by 14
Beisel, C., Jordan-Paiz, A., Köllmann, S., Ahrenstorf, A. E., Padoan, B., Barkhausen, T., Addo, M. M., & Altfeld, M. A. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00495-x · Cited by 13
Pereira, M. C. A., Ramalho, T. R. D. O., Andrade, W. A., Durso, D. F., de Souza, M. C. N., Fitzgerald, K. A., Golenbock, D. T., Silverman, N. S., & Gazzinelli, R. T. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113795 · Cited by 13
Controlling systems of nucleic acid sensing-TLRs restrict homeostatic inflammation
Fukui, R., & Miyake, K. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.032 · Cited by 13
Keppler, M., Straß, S., Geiger, S., Fischer, T., Späth, N., Weinstein, T., Schwamborn, A., Guezguez, J., Guse, J., Laufer, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1168252 · Cited by 14
Differential Gene Expression Downstream of Toll-like Receptors (TLRs)
Nguyen, T. T., Johnsen, I. B., Knetter, C. F., Drabløs, F., Fitzgerald, K. A., Lien, E., & Anthonsen, M. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068817 · Cited by 13
Gan, L., & Li, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.12.004 · Cited by 13
Yang, C., Meng, J., Li, W., Zhao, Y., Li, J., Wen, Y., Liu, S., Cheng, X., Mi, S., Huo, H., et al. (2025) · Small · doi:10.1002/smll.202508378 · Cited by 12
A parasite odyssey: An RNA virus concealed in Toxoplasma gondii
Gupta, P., Hiller, A., Chowdhury, J., Lim, D., Lim, D. Y., Saeij, J. P. J., Babaian, A., Rodriguez, F., Pereira, L., & Morales-Tapia, A. (2024) · Virus Evolution · doi:10.1093/ve/veae040 · Cited by 12
New application of anti-TLR monoclonal antibodies: detection, inhibition and protection
Fukui, R., Murakami, Y., & Miyake, K. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0068-7 · Cited by 22
Pimenta, E. M., & Barnes, B. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0305-5 · Cited by 12
Transcriptomic effects of estradiol treatment on cultured human uterine smooth muscle cells
Chandran, S., Cairns, M. T., O’Brien, M., & Smith, T. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.05.020 · Cited by 11
Liang, C., Tang, Y., Gao, X., Lei, N., Luo, Y., Chen, P.-R., Duan, S.-H., Cao, Y., Yang, Y., & Zhang, Y. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07679-2 · Cited by 7
Manfrere, K. C. G., Torrealba, M. P., Miyashiro, D., Oliveira, L. M. D. S., de Carvalho, G. C., de Lima, J. F., Branco, A. C. C. C., Pereira, N. Z., Pereira, J. C., Sanches, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12816 · Cited by 10
Metadata
- Authors
- Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Johns Hopkins University (US)
- Corresponding author
- Fitzgerald, Katherine A.
- Golenbock, Douglas T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 280
- Issue
- 17
- Pages
- 17005-17012
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040706148
- Cited by
- 411
- References
- 72
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 16 · 2023: 16 · 2022: 11 · 2021: 13 · 2020: 16 · 2019: 21 · 2018: 23 · 2017: 25 · 2016: 11 · 2015: 14 · 2014: 25 · 2013: 17 · 2012: 20
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Cancer Institute (R01A1/CA19737-19A1)
- National Institute of General Medical Sciences (GM 54060)
- National Institute of Allergy and Infectious Diseases (AI-52455, AI 49309, R01AI049309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- IRF5, IRF7, TLR7, TLR8, TLR7 signaling, type I interferon, MyD88, TRAF6, IRAK1, IRF3, interferon regulatory factors, R848, innate immunity
- MeSH terms
- Antigens, Differentiation, Biological Assay, Cell Line, DNA-Binding Proteins, Dose-Response Relationship, Drug, Glutathione Transferase, Humans, Interferon Type I, Ligands, Lipopolysaccharides, Membrane Glycoproteins, Models, Biological, Phosphorylation, Receptors, Cell Surface, Receptors, Immunologic, Recombinant Fusion Proteins, RNA, Double-Stranded, Time Factors, Transcription Factors, Transfection, Signal Transduction, Genes, Reporter, Electroporation, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Interferon Regulatory Factors, Interferon Regulatory Factor-3, Interferon Regulatory Factor-7, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 4, Toll-Like Receptor 7, Toll-Like Receptor 8, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review